EMUC18: MDT work is crucial for optimal management of urological cancers
May 30, 2018Read moreIt is well-known that optimal management of urological malignancies is best achieved through multidisciplinary teams (MDT), but more than...
0Improving reporting systems, defining selection criteria in PCa diagnosis
September 7, 2017Read moreDespite gains in imaging technology and molecular research, pathologists engage in prostate cancer diagnosis are faced with dissimilar reporting...
EMUC17: Using biomarkers in decision-making for RCC treatment
September 5, 2017Read moreRenal cell carcinomas are among the most lethal in urological malignancies prompting doctors to search for tools such as...
EMUC17: Bladder cancer- Challenges in immunotherapy
July 31, 2017Read moreImmunotherapy is widely anticipated to offer a more prominent role in managing urological cancers but there are unresolved issues...
EMUC17: Crucial need to standardize MRI use and reporting
July 17, 2017Read moreThere is an urgent need to standardize acquisition, interpretation and reporting of whole body Magnetic Resonance Imaging (MRI) to...
EMUC17: Examining key topics in urothelial carcinoma
June 29, 2017Read moreRisk assessment and evaluation of disease extent remain crucial elements in the optimal treatment and management of upper tract...
FALCON Workshop focuses on salvage intra-prostatic relapses
December 5, 2016Read moreThe European SocieTy for Radiotherapy & Oncology (ESTRO) organised the educational and multifunctional FALCON (Fellowship in Anatomic delineation and...
EMUC16: National cancer plans – Key element in cancer prevention
November 29, 2016Read moreThe role of national cancer plans cannot be underestimated and remains a key element for an effective pan-European cancer...
EMUC16: High sensitivity urine biomarkers to detect bladder cancer
November 29, 2016Read moreAn investigational, follow-up study by Greek researchers on three urine biomarkers to detect bladder cancer (BCa) has won the...
